Literature DB >> 552411

Cancer chemotherapy.

R J Wrighton.   

Abstract

Mesh：

Year:  1979        PMID： 552411      PMCID： PMC1436732          DOI： 10.1177/014107687907200101

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  10 in total

1.  Prolonged remission maintenance in acute myeloid leukaemia.

Authors:  A S Spiers; J M Goldman; D Catovsky; C Costello; D A Galton; C S Pitcher
Journal:  Br Med J       Date:  1977-08-27

2.  Radiotherapy in the treatment of Hodgkin's disease.

Authors:  A R Timothy; S B Sutcliffe; A G Stansfeld; P F Wrigley; A E Jones
Journal:  Br Med J       Date:  1978-05-13

3.  Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

Authors:  T A Lister; M H Cullen; M E Beard; R L Brearley; J M Whitehouse; P F Wrigley; A G Stansfeld; S B Sutcliffe; J S Malpas; D Crowther
Journal:  Br Med J       Date:  1978-03-04

4.  Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors:  G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

5.  The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.

Authors:  G Bonadonna; A Rossi; P Valagussa; A Banfi; U Veronesi
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

6.  Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.

Authors:  P A Chahinian; D J Arnold; J M Cohen; D P Purpora; I S Jaffrey; A S Teirstein; P A Kirschner; J F Holland
Journal:  JAMA       Date:  1977-05-30       Impact factor: 56.272

7.  Combination chemotherapy for acute lymphoblastic leukaemia in adults.

Authors:  T A Lister; J M Whitehouse; M E Beard; R L Brearley; P F Wrigley; R T Oliver; J E Freeman; R K Woodruff; J S Malpas; A M Paxton; D Crowther
Journal:  Br Med J       Date:  1978-01-28

8.  Dare we count the cost of cancer chemotherapy?

Authors:  R J Berry; G Bryan
Journal:  Lancet       Date:  1978-09-02       Impact factor: 79.321

9.  MVPP chemotherapy regimen for advanced Hodgkin's disease.

Authors:  S B Sutcliffe; P F Wrigley; J Peto; T A Lister; A G Stansfeld; J M Whitehouse; D Crowther; J S Malpas
Journal:  Br Med J       Date:  1978-03-18

10.  Management of trials in the development of cancer chemotherapy.

Authors:  C J Williams; S K Carter
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.